Using four ATF7IP enhancer-targeting sgRNAs, we found a 50% reduction in ATF7IP expression (Fig. 4D), further demonstrating this BC-associated enhancer as a regulator of ATF7IP expression. Here, ATF7IP is linked to breast cancer.